Genentech

AVASTIN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Avastin HCPCS:

J9035

HCPCS Code Descriptor:

Injection, bevacizumab, 10 mg

Category:

J Code

Avastin NDCs:

50242-0061-01, 50242-0060-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Avastin CPT Codes:

Potential CPT administration codes for Avastin can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Avastin:

AVASTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9035 is aligned to the drug AVASTIN.

Avastin works in combination with certain chemotherapies and is used to prevent tumor growth in various types of cancer. By blocking the growth of new blood vessels that cancer cells depend on, Avastin should stop cancer cells from growing and reproducing. As of 2023, there are multiple biosimilar drugs available for Avastin including Mvasi (Q5107), Riabni (Q5123), and Zirabev (Q5118).

ACCESS PRICING AND MORE BY REGISTERING

J9035 Added Date:

January 1, 2005

J9035 Effective Date:

January 1, 2005

J9035 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Avastin billing and coding information.
Avastin patient assistance information can be found through Genentech at the URL: https://www.avastin.com/hcp/contact-a-representative.html
AVASTIN prescribing information can be found at the link below:
Information regarding AVASTIN’s side effects can be found at MedlinePlus